Published: Sept. 29, 2009
Updated: Sept. 29, 2009
It is overwhelming to have your child referred to a pediatric pulmonologist for breathing difficulties.
It is especially stressful when it is your infant, unable to describe what is wrong with his or her breathing, and unable to undergo many of the standard tests we do in our clinic to help diagnose the problem.
At Duke, we are able to provide physicians and families with state-of-the-art equipment to help us understand what is happening with an infant or small child’s lungs. This study is called Infant Pulmonary Function Testing and is only available at certain hospitals and facilities across the country.
Stacey Peterson-Carmichael, MD, of Duke's Divisions of Pediatric Critical Care and Pediatric Pulmonary and Sleep Medicine explains what we need to know about this test.
-- Dennis Clements, MD, PhD, MPH
Detecting early lung disease in infants and young children with various illnesses -- such as cystic fibrosis (CF) -- may lead to earlier intervention and improved prognosis.
Infant lung function testing may be helpful in characterizing the progression of early lung disease.
With the recent implementation of newborn screening for CF in North Carolina, identifying early CF lung disease is critical for developing future therapies as well as helping the clinicians who care for the young patient with CF.
In addition to providing this clinical testing, Duke will soon launch several research studies using IPFT’s to help us better understand chronic lung disease of infancy, congenital diaphragmatic hernia and lung injury in various other disease states.
-- Stacey Peterson-Carmichael, MD, is a physician in Duke's Divisions of Pediatric Critical Care and Pediatric Pulmonary and Sleep Medicine, and director of the Infant Lung Function Laboratory at Duke Children's Hospital.
-- Dennis Clements, MD, PhD, MPH, is the chief of primary care pediatrics at Duke Children's Hospital.